(VIANEWS) - ASML Holding (ASML), Johnson & Johnson (JNJ), Travelzoo (TZOO) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ASML Holding (ASML)
31.2% sales growth and 43.26% return on equity
ASML Holding N.V. designs, manufactures, markets, sells and services high-quality semiconductor equipment systems that include lithography systems for logic and memory chipmakers.
ASML Holding's sales growth this year is anticipated to be 13.8% and 11.2% for next year.
Year-on-year quarterly revenue growth grew by 32.4%, now sitting on 17.88B for the twelve trailing months.
Volume
Today's last reported volume for ASML Holding is 814154 which is 30.62% below its average volume of 1173630.
ASML Holding's sales growth for the next quarter is 31.2%. The company's growth estimates for the ongoing quarter and the next is a negative 53.2% and 58.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 43.26%.
Volatility
ASML Holding's last day, last week, and last month's current intraday variation average was 2.49%, 2.17%, and 2.11%, respectively.
ASML Holding's highest amplitude of average volatility was 3.42% (day), 3.27% (last week), and 3.08% (last month), respectively.
ASML Holding's Stock Yearly Top and Bottom Value
ASML Holding's stock is valued at $597.87 at 06:22 EST, way under its 52-week high of $895.93 and above its 52-week low of $558.77.
ASML Holding's Moving Average
ASML Holding's worth is under its 50-day moving average of $648.53 and way below its 200-day moving average of $746.56.Previous days news about ASML Holding(ASML)
- According to Bloomberg Quint on Wednesday, 13 April, "While Nikon and rival Canon Inc. once competed in the market, ASML Holding NV now dominates the top end of the market. "
- According to Bloomberg Quint on Thursday, 14 April, "The Netherlands wants to build a new national chip champion akin to ASML Holding NV with an investment of 1.1 billion euros ($1.2 billion) in next-generation photonic technology."
2. Johnson & Johnson (JNJ)
8.4% sales growth and 30.41% return on equity
Johnson & Johnson develops, manufactures and markets various products for the global health care industry.
Johnson & Johnson's sales growth this year is anticipated to be 14.2% and 3.9% for next year.
Year-on-year quarterly revenue growth grew by 10.4%, now sitting on 93.78B for the twelve trailing months.
Volume
Today's last reported volume for Johnson & Johnson is 6174620 which is 23.34% below its average volume of 8055270.
Johnson & Johnson's sales growth for the next quarter is 8.4%. The company's growth estimates for the ongoing quarter and the next is 14% and 1.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 30.41%.
Volatility
Johnson & Johnson's last day, last week, and last month's current intraday variation average was 0.18%, 0.88%, and 1.15%, respectively.
Johnson & Johnson's highest amplitude of average volatility was 1.37% (day), 2.03% (last week), and 1.98% (last month), respectively.
Johnson & Johnson's Stock Yearly Top and Bottom Value
Johnson & Johnson's stock is valued at $179.90 at 06:22 EST, under its 52-week high of $183.19 and way above its 52-week low of $155.72.
Johnson & Johnson's Moving Average
Johnson & Johnson's value is higher than its 50-day moving average of $171.67 and above its 200-day moving average of $168.41.Previous days news about Johnson & Johnson(JNJ)
- According to Bloomberg Quint on Thursday, 14 April, "In the U.S., the club drug and anesthetic ketamine, and a related FDA-approved compound esketamine, developed by Johnson & Johnson as a nasal spray, are already available in such facilities."
- According to Bloomberg Quint on Thursday, 14 April, "The continent's biggest drugmaker is making the doses on behalf of Johnson & Johnson at a plant in South Africa and in March said it agreed to make those shots under its own brand. "
- According to The Wall Street Journal on Sunday, 17 April, "They are just a few of the dozens of big U.S. companies, from Bank of America Corp. to Johnson & Johnson to Tesla Inc. , expected to post results."
3. Travelzoo (TZOO)
8.4% sales growth and 26.65% return on equity
Travelzoo is an Internet media company that offers entertainment and travel deals to local businesses and travel companies in Asia Pacific, Europe and North America.
Travelzoo's sales growth this year is expected to be 23.3% and 20.6% for next year.
Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 62.71M for the twelve trailing months.
Volume
Today's last reported volume for Travelzoo is 156384 which is 148.41% above its average volume of 62954.
Travelzoo's sales growth for the next quarter is 8.4%. The company's growth estimates for the current quarter and the next is 142.9% and negative -9.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.65%.
Volatility
Travelzoo's last day, last week, and last month's current intraday variation average was 1.23%, 1.95%, and 4.91%, respectively.
Travelzoo's highest amplitude of average volatility was 5.85% (day), 6.65% (last week), and 9.29% (last month), respectively.
Travelzoo's Stock Yearly Top and Bottom Value
Travelzoo's stock is valued at $6.51 at 06:22 EST, way under its 52-week high of $18.47 and way higher than its 52-week low of $5.20.
Travelzoo's Moving Average
Travelzoo's worth is way under its 50-day moving average of $8.01 and way below its 200-day moving average of $10.69.4. Paychex (PAYX)
5.8% sales growth and 42.57% return on equity
Paychex, Inc. offers integrated solutions in human capital management for HR, payroll, benefits, insurance, and other services to small and medium-sized companies throughout the United States.
Paychex's sales growth this year is expected to be 10.5% and 6.6% for next year.
Year-on-year quarterly revenue growth grew by 12.7%, now sitting on 4.33B for the twelve trailing months.
Volume
Today's last reported volume for Paychex is 1574920 which is 21.5% below its average volume of 2006330.
Paychex's sales growth is a negative 0% for the present quarter and 5.8% for the next. The company's growth estimates for the ongoing quarter and the next is 8.3% and 8.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 42.57%.
Volatility
Paychex's last day, last week, and last month's current intraday variation average was 1.33%, 1.80%, and 1.51%, respectively.
Paychex's highest amplitude of average volatility was 3.32% (day), 3.23% (last week), and 2.64% (last month), respectively.
Paychex's Stock Yearly Top and Bottom Value
Paychex's stock is valued at $136.69 at 06:22 EST, under its 52-week high of $141.92 and way above its 52-week low of $95.01.